TARGETING ACTIVATED LYMPHOCYTES WITH AN ENTIRELY HUMAN IMMUNOTOXIN ANALOGUE: HUMAN PANCREATIC RNASE1-HUMAN IL-2 FUSION
- 30 June 2000
- Vol. 12 (6) , 786-790
- https://doi.org/10.1006/cyto.1999.0619
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 10 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Human pancreatic RNase1-human epidermal growth factor fusion: an entirely human 'immunotoxin analog' with cytotoxic properties against squamous cell carcinomasProtein Engineering, Design and Selection, 1998
- Interleukin-2 fusion protein: An investigational therapy for interleukin-2 receptor expressing malignanciesEuropean Journal Of Cancer, 1997
- Inhibition of HIV-1 Production and Selective Degradation of Viral RNA by an Amphibian RibonucleaseJournal of Biological Chemistry, 1996
- Immunotoxins: An UpdateAnnual Review of Immunology, 1996
- Recombinant Human Pancreatic Ribonuclease Produced in E. coli : Importance of the Amino-Terminal SequenceBiochemical and Biophysical Research Communications, 1995
- HTLV-1 oncoprotein Tax deregulates transcription of cellular genes through multiple mechanismsZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- A Study of the Intracellular Routing of Cytotoxic RibonucleasesPublished by Elsevier ,1995
- The Human Immunodeficiency Virus: Infectivity and Mechanisms of PathogenesisScience, 1988
- Variation in the clinical courses of adult T-cell leukemiaCancer, 1985